Catechol-O-methyltransferase (COMT) inhibitors have long been recognised for their clinical utility in managing neurological disorders, most notably Parkinson’s disease. By impeding the enzymatic ...
Baltimore, Maryland (March 31, 2025) — The Lieber Institute for Brain Development, a nonprofit research institution dedicated to treating and preventing developmental brain disorders, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback